We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




SNP Genotyping Platform Accurately Identifies Rare Donor Blood Types

By Biotechdaily staff writers
Posted on 10 Jul 2008
A single nucleotide polymorphism (SNP) genotyping platform enables faster screening for accurate identification of rare donor blood types. More...


There are many antigens located on the outer surface of the erythrocyte. Combinations of these blood group antigens vary between individuals even within the same A, B, or O blood type. The specificity of the antibodies in a recipient's blood and the prevalence of antigens in the donor population complicate the task of locating appropriate donors.

The OpenArray SNP genotyping platform, based on through-hole nanoliter fluidics technology, allows scientists to conduct up to 3,072 independent polymerase chain reaction (PCR) analyses simultaneously on a thin metal plate the size of a microscope slide. Developed by BioTrove (Woburn, MA, USA) the genotyping platform expands the capabilities of PCR.

BioTrove Inc. and BloodCenter of Wisconsin (Milwaukee, WI, USA) are collaborating to develop single SNP genotyping as a screening tool for identification of better-matched blood for transfusion. They will use the BioTrove OpenArray system to conduct erythrocyte genotyping more quickly and more economically. BloodCenter of Wisconsin will be able to stratify blood donors based on genotypic characteristics, improving the speed and accuracy of blood transfusions for patients in need.

BloodCenter's diagnostic laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The specialized testing and medical consultation provided by the diagnostic laboratories benefit patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders, and patients with immunologic, neoplastic, or genetic diseases.


Related Links:
BioTrove
BloodCenter of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Portable POCT Blood Gas Analyzer
BD100
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.